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ABSTRACT 
In the literature, the terms physical inactivity and immobilization are largely used as 
synonyms. The present review emphasizes the need to establish a clear distinction between 
these two situations. Physical inactivity is a behavior characterized by a lack of physical 
activity, whereas immobilization is a deprivation of movement for medical purpose. In 
agreement with these definitions, appropriate models exist to study either physical inactivity 
or immobilization, leading thereby to distinct conclusions. In this review, we examine the 
involvement of oxidative stress in skeletal muscle insulin resistance and atrophy induced by, 
respectively, physical inactivity and immobilization. A large body of evidence demonstrates 
that immobilization-induced atrophy depends on the chronic overproduction of reactive 
oxygen and nitrogen species (RONS). On the other hand, the involvement of RONS in 
physical inactivity-induced insulin resistance has not been investigated. This observation 
outlines the need to elucidate the mechanism by which physical inactivity promotes insulin 
resistance.  
INTRODUCTION 
The terms physical inactivity and immobilization are a source of confusion in the literature. 
Most of the conclusions drawn on physical inactivity are based on results from 
immobilization experiments [1, 2]. Physical inactivity is a behavior characterized by a lack of 
physical exercise, whereas immobilization is a clinical state in which one limb or whole body 
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is mechanically unloaded. Although immobilization belongs to the continuum of physical 
inactivity, it is an extreme situation, requiring a distinct experimental design. On the one 
hand, immobilization is investigated in human through several models such as bed rest, 
casting and unilateral lower limb suspension. In rodents, hindlimb unloading remains the 
reference model of immobilization [3]. On the other hand, physical inactivity is 
experimentally reproduced with the reduction of the daily number of steps from 10,000 to 
1,500-3,000 in human or with the locked-wheel model in rodents [4, 5]. From physical 
inactivity to immobilization, decline of muscle load promotes insulin resistance and atrophy 
[6, 7], pathological states in which the overproduction of reactive oxygen and nitrogen species 
(RONS) seems a common denominator [8, 9]. Herein, we will focus this review on the role of 
RONS on skeletal muscle insulin resistance and atrophy in the context of physical inactivity 
and immobilization. To avoid confusion, we chose to make a clear distinction between 
physical inactivity and immobilization (see Figure 1). 
 
Physical inactivity: definition, causes and consequences  
Physical inactivity is basically defined as a lack of physical activity [10]. The World 
Health Organization (WHO) established a threshold, separating inactive vs. active humans, 
based on the metabolic equivalent of task (MET), one MET being the minimum power 
required to maintain the basal metabolism. According to WHO, active adult performs at least 
150 minutes of moderate-intensity (3.0–5.9 MET) physical activity per week or at least 75 
minutes of vigorous-intensity (≥6.0 MET) physical activity per week or an equivalent 
combination of moderate- and vigorous-intensity activity achieving 600 MET-minutes score 
per week [11]. In children and adolescents (5-17 years old), physical inactivity is defined as 
not meeting 60 minutes of moderate to vigorous-intensity physical activity daily [11]. Based 
on these definitions, the worldwide prevalence of physical inactivity reaches 31% in adults 
and 80% in adolescents [12]. This high proportion of inactive people contrasts with the 
singular capacity of human for long endurance exercises [13]. 
In the genus Homo, a high level of physical activity was an adaptive behavior required 
for food procurement, escape from predators, social interactions and search for shelter. During 
the last two centuries, the scientific progress radically changed conditions which drove 
hominid evolution for 7 million years. By replacing human work with machines, the industrial 
revolution initiated a drastic reduction of physical activity. Since then, the development and 
democratization of new technologies have strengthened this phenomenon. In modern society, 
physical activity, instead of vital, became a leisure which is not practiced by a large part of the 
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population. In the beginning of the 20th century, the sedentary behavior was firstly encouraged 
by the scientific community which pointed out the hazards of exercise [14]. A turning point 
operated when, in 1953, Morris and Heady published a large scale epidemiological study 
highlighting the deleterious effect of physical inactivity on health. In this study, the authors 
concluded: “physical work may be a way of life conducive to good health” [15].  
First seen as a progress, the reduction of physical activity is now recognized as a major 
factor contributing to the burden of non-communicable diseases [12]. After smoking, physical 
inactivity is the second risk factor for non-communicable diseases, responsible for 5.3 million 
deaths per year worldwide [16]. In addition, Pedersen proposed a “diseasome of physical 
inactivity”, gathering cardiovascular disorders, different types of cancer, type 2 diabetes, 
depression and dementia [4]. Worldwide, Lee et al. [16] estimate that physical inactivity 
causes 6% of the coronary heart disease, 7% of type 2 diabetes and 10% of breast and colon 
cancers. Among these diseases, the most alarming is likely type 2 diabetes, a pathological 
state characterized by insulin resistance. In the United States, diabetes affects 9.3% of the 
population and the total cost reaches 245 billion dollars per year [17].  
 
Immobilization: definition, causes and consequences  
Immobilization is a deprivation of movement for medical purpose of either a limb or 
whole body. It is noteworthy that the cause is independent of the will and the consequences on 
biology are almost immediate, thus contrasting with physical inactivity. Due to medicine 
progress and aging of the population, more and more people are immobilized in hospital or at 
home. In the United States, hospitalization related to aging increased by 11.8% between 2005 
and 2015 [18]. For instance, osteoporotic hip fracture is estimated to reach 300,000 cases 
annually in the United States [19]. Given that the proportion of elderly will increase, the 
number of hospitalizations is expected to rise in the future [20].  
Whatever the cause, the major complication for bedridden patients is the rapid 
development of skeletal muscle atrophy [21-23], a collateral damage which poses challenging 
health issues. Indeed, skeletal muscle atrophy is associated with a loss of strength, a situation 
which promotes functional deficits, exacerbates illness and complicates patient recovery, 
especially in the elderly [24]. In this population, immobilization constitutes a major risk factor 
for functional decline and loss of autonomy [25]. Consequently, the prevention of skeletal 
muscle atrophy is crucial for patients, medical team and healthcare system [24, 26].  
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SKELETAL MUSCLE OXIDATIVE STRESS IN IMMOBILIZATION AND 
PHYSICAL INACTIVITY 
Source of RONS in skeletal muscle  
From immobilization to strenuous physical exercise, RONS production in skeletal muscle 
follows a U-shaped curve [27]. This representation brings out the RONS paradox, good 
friends when associated with physical activity but bad guys when induced by an absence of 
physical activity. Herein, we will present the main mechanisms leading to RONS production 
in skeletal muscle. 
Sequential univalent reduction of dioxygen produces oxidant molecules collectively 
named reactive oxygen species (ROS). The primary ROS generated, superoxide (O2x-), gives 
rise to others ROS, e.g., hydrogen peroxide (H2O2) and the highly toxic hydroxyl radical 
(HOx). In skeletal muscle, ROS are produced by: 1) mitochondria; 2) nicotinamide adenine 
dinucleotide phosphate (NADPH) oxidase (NOX); 3) phospholipase A2 (PLA2); 4) xanthine 
oxidase (XO); 5) endoplasmic reticulum (ER). 
In the mitochondria, electrons from NADH and FADH2 are transferred from electron 
donor to electron acceptor molecules in a process coupled with energy production. Electrons 
are transported through four enzymatic complexes (I, II, III, IV) known as electrons transport 
chain. During this process, a small part of the electrons leaks, mainly through complex I, 
reduced dioxygen thus leading to O2x- formation [28]. According to in vitro experiments, it 
has been proposed that 0.12-2% of dioxygen consumed by mitochondria is converted into O2x- 
[28]. However, these values cannot be generalized to the in vivo situation, and depend on 
several factors such as oxidized substrate, mitochondria respiratory states, fiber types and 
electron donor concentration [27, 28]. Whatever the exact proportion of dioxygen converted 
into O2x-, mitochondria is a major source of ROS in skeletal muscle [29]. 
The enzymatic complex NOX catalyzes the NADPH-dependent reduction of dioxygen to 
produce O2x-. In immune cells such as neutrophils and macrophages, NOX2 (also called 
gp91phox) is used as a «superoxide gun» to kill pathogens during phagocytosis [30]. In 
addition to the phagocyte NOX2, six non-phagocytic NOXs have been identified: NOX1, 
NOX3, NOX4, NOX5, DUOX1 and DUOX2 [31]. Skeletal muscle expressed NOX2 and 
NOX4, located in the sarcoplasmic reticulum, the sarcolemma and transverse tubules [29, 32]. 
It has been reported that NOX4 is constitutively active and directly produces hydrogen 
peroxide [33]. Although NOXs contributes to skeletal muscle ROS production both at rest and 
during exercise, their physiological functions remain unidentified in myocytes.  
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PLA2 hydrolyses membrane phospholipid and releases arachidonic acid. This lipid serves 
as a substrate for the lipoxygenases, a reaction coupled with the reduction of dioxygen into 
O2x- [34]. Furthermore, PLA2 could stimulate NOXs and mitochondria O2x- production [27]. 
Gong et al. proposed that PLA2-dependent process generates O2x- in skeletal muscle under 
resting and exercise conditions [35]. 
XO and xanthine dehydrogenase (XDH) are isoenzymes of xanthine oxidoreductase 
(XOR), whose activities have been well identified during ischemia-reperfusion phenomenon. 
During ischemia, energy-starved tissues catabolize ATP to hypoxanthine. Calcium activates 
specific proteases which convert XDH to XO by cleavage. Then, XO catalyzes the oxidation 
of hypoxanthine and xanthine to produce respectively xanthine and acid uric, these reactions 
are coupled with the reduction of dioxygen into O2x-. Interestingly, XO is likely a major 
source of ROS in skeletal muscle during exercise [36]. However, in this tissue, XO seems 
present in capillary endothelium and infiltrated leucocytes rather than in myocytes [37]. 
ER lumen is highly oxidant compared to cytosol [38], this unique environment allows the 
formation of disulfide bonds, a process generating ROS. Inside the ER, electrons from 
oxidized thiol groups are accepted by the protein disulfide isomerase and then transferred to 
the endoplasmic reticulum oxidoreductin-1-like protein (ERO1). Finally, ERO1 transfers 
electrons to oxygen and produces H2O2 [39]. Although this source of ROS is usually not 
mentioned, it has been estimated that ER could be responsible for up to 25% of ROS 
generated during protein synthesis [40].  
 
The primary reactive nitrogen species (RNS) generated, nitric oxide (xNO), give rises to 
others RNS such as nitrogen dioxide (xNO2) and the highly aggressive peroxynitrite (ONOO-
). In the cells, xNO is mainly synthetized from L-arginine, a reaction catalyzed by enzymes 
belonging to the nitric oxide synthase (NOS) family. In skeletal muscle, three NOS are 
expressed: 1) neuronal NOS (NOS1 or nNOS); 2) inducible NOS (NOS2 or iNOS); 3) 
endothelial NOS (NOS3 or eNOS). In skeletal muscle, NOS1 and NOS3 are constitutively 
expressed while NOS2 is mainly found under inflammatory condition [41]. NOS1 is typically 
present in the sarcolemma linked to the dystrophin complex, whereas NOS3 seems localized 
in the mitochondria [27, 42]. When expressed, NOS2 is likely localized in the cytosol [43]. It 
is noteworthy that localization of NOSs in skeletal muscle is still under debate. Indeed, NOS1 
has also been found in the sarcoplasm and the Golgi apparatus, whereas identification of the 
mitochondrial NOS remains controversial [41]. 
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In physiological conditions, RONS are signaling molecules, involved in essential 
processes such as insulin action, immune response, apoptosis, autophagy, mitochondria 
biogenesis and differentiation [8, 29, 41]. On the other hand, continuous and high 
concentration of RONS induces oxidative and irreversible damage to proteins, lipids, RNA 
and DNA. In skeletal muscle, oxidation of these biomolecules participates in the development 
of insulin resistance and atrophy [44, 45]. Thus, an efficient antioxidant system is required to 
maintain RONS concentration in a physiological range. 
 
Antioxidant defense in skeletal muscle 
Antioxidant defense gathers enzymatic and non-enzymatic systems, acting in a 
complementary manner within cells, extracellular and vascular space. The enzymatic defenses 
mainly include superoxide dismutase (SOD), catalase and glutathione peroxidase (GPx), 
whereas non-enzymatic defenses include multiple molecules such as reduced glutathione 
(GSH), vitamin E and vitamin C. 
In mammals, three isoforms of SOD have been identified: SOD1, SOD2 and SOD3. 
SOD1 is present in the cytosol and the mitochondrial intermembrane space, SOD2 is found in 
the mitochondrial matrix and SOD3 is localized in the extracellular space [27]. SOD1/SOD3 
and SOD2 use, respectively, copper-zinc and manganese as a co-factor. By catalyzing the 
dismutation of O2x- into H2O2, SOD limits O2x- content. However, the product of this reaction, 
H2O2, can exert a wide range of deleterious effects due to its relative long half-life and high 
diffusion capacity [29]. Thus, H2O2 concentration must be tightly limited in the cells. 
The removal of H2O2 is performed by both catalase and GPx [46]. Catalase requires heme 
iron as a co-factor to convert H2O2 into water and dioxygen [47]. This enzyme is widely 
distributed in the cell but predominates in peroxisomes [27, 48]. GPx catalyzes the reduction 
of H2O2 into water by using an electron donor, GSH, which is converted into its oxidized 
form GSSG. GPx is mainly localized in cytosol and mitochondria [27]. It is noteworthy that, 
compared to the glycolytic fibers, the oxidative fibers contain a higher level of SOD, catalase 
and GPx [49]. 
A wide range of non-enzymatic antioxidants are present in cells (e.g., GSH, vitamin C, 
vitamin E and β-carotene), only GSH will be mentioned herein. Ubiquitous and present in all 
parts of the cells, the tripeptide GSH is a major antioxidant [50]. As aforementioned, GSH 
serves as a substrate in the reaction catalyzed by GPx but it is also a reducing agent which 
exerts a direct antioxidant action. In addition, GSH allows the recycling of vitamin E and C, 
thus maintaining their antioxidant power [49].  
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 Skeletal muscle oxidative stress in immobilization and physical inactivity  
Oxidative stress has been extensively studied in skeletal muscle, especially during 
exercise [27], and more recently during immobilization [51]. In contrast, much less attention 
has been paid to alteration of the redox system induced by physical inactivity. It is noteworthy 
that, studies comparing sedentary behavior to lifelong exercise will not be discussed in this 
review. Indeed, those ways of life are studied in the context of aging, a process well-known to 
promote oxidative stress. Thus, aging constitutes a cofounding factor preventing to isolate the 
effects of physical inactivity on oxidative stress. For the same reason, studies dealing with 
aging and immobilization will not be discussed in this review. To the best of our knowledge, 
no studies characterized the effects of physical inactivity on muscle oxidative stress. 
Consequently, we will focus on the effects of immobilization on muscle oxidative stress.  
Data from animals, and more recently from humans, indicate that immobilization 
increases O2x- and H2O2 emissions in skeletal muscle [52-56]. Mitochondria contributes to 
muscle ROS production during immobilization [52, 54-56], but other studies highlight that 
XO plays also an important role [57, 58]. To the best of our knowledge no studies reported 
that NOX, NOS or ER plays a role in the production of ROS induced by immobilization. ROS 
production promotes the activation of non-enzymatic and enzymatic antioxidant systems. On 
one hand, the ratio GSH/GSSG decreases in skeletal muscle during hindlimb unloading [59-
61]. On the other hand, immobilization causes, in skeletal muscle, an increase of SOD1 and 
catalase protein content and activities [53, 57, 59, 61-64], whereas SOD2 protein content and 
activity do not change [61, 63-65].  
Although immobilization increases ROS production and upregulates antioxidant 
defenses, the effects on macromolecular damage are less clear. Carbonylation of proteins is 
frequently measured to determine oxidative damage during immobilization. The few studies 
conducted in human observed that carbonylated protein levels did not change in the vastus 
lateralis after 8 and 14 days of bed rest [66, 67], but became higher after 35 days [66]. In 
rodents, some studies reported an increase of carbonylated proteins in the soleus during the 
first week of hindlimb unloading [57, 68-70], whereas other reports did not observed such 
effect after 3, 7 and 14 days of hindlimb unloading [53, 60, 62]. A more restricted number of 
studies focused on the effects of immobilization on α,β-unsaturated aldehydes (e.g., 4-HNE, 
MDA), markers of lipid peroxidation. 4-HNE content increased in rat soleus after 8 days of 
hindlimb unloading [64, 71], whereas elevations in MDA and TBARS contents were reported 
after 10 and 14 days of hindlimb unloading, respectively [61, 69]. All together, these results 
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suggest that immobilization first induced lipid peroxidation and later protein carbonylation in 
skeletal muscle. In this context, elevation of 4-HNE level could be an early event contributing 
to protein carbonylation via Michael addition cascade [72].  
Presently, oxidative stress is no longer seen as disequilibrium between pro- and 
antioxidant. Indeed, this reductive approach implies that oxidative stress depends on a single 
balance, thus setting aside the diversity and complexity of the redox system. To bypass this 
difficulty, oxidative stress is currently defined from its endpoint: “macromolecular damage, 
and disruption of thiol redox circuits, which leads to aberrant cell signaling and dysfunctional 
redox control” [73]. Based on this definition, data presented in this section lead us to conclude 
that immobilization induces oxidative stress in skeletal muscle. 
 
ROLE OF OXIDATIVE STRESS IN IMMOBILIZATION-INDUCED SKELETAL 
MUSCLE ATROPHY 
Cellular mechanisms involved in immobilization-induced skeletal muscle atrophy 
Myocytes are postmitotic cells like neurons or cardiomyocytes, whose size are de facto 
regulated by the balance between protein synthesis and degradation. Despite the debate 
concerning the dominant mechanism of immobilization-induced muscle atrophy [74], the 
scientific community agrees that protein turnover is altered in this pathological process.  
Immobilization causes a rapid decrease of protein synthesis in rodent and human skeletal 
muscle. Indeed, numerous studies demonstrated that a reduction in muscle protein fractional 
synthesis rate (FSR) occurs in the first days of immobilization [53, 75, 76]. This rapid 
reduction of protein synthesis persists for several weeks since a decrease of muscle FSR has 
been also reported in human skeletal muscle after 14 and 28 days of bed rest [77, 78]. Protein 
synthesis is mainly modulated at the translation level through the PI3K (phosphatidyl inositol 
3-kinase)/Akt/mTORC1 (mammalian target of rapamycin) pathway [79]. Specifically, 
mTORC1 enhances the formation of the 40S ribosomal subunit through the phosphorylation 
of the 4E binding protein 1 (4E-BP1) and the ribosomal protein S6 kinase (S6K). 
Phosphorylation of 4E-BP1 and S6K induce their activation and dissociation from eukaryotic 
initiation factor 4E (eIF4E) and eIF3, respectively, allowing the formation of the 40S 
ribosomal subunit. Interestingly, skeletal muscle exhibits alteration in PI3K/Akt/mTORC1 
axis during immobilization [75, 76, 80-82]. This phenomenon, called anabolic resistance, 
emphasizes the reduced response to anabolic stimuli [80, 82].  
Under apoptosis, the loss of myonuclei is another mechanism proposed to explain the 
reduced ability of myocytes to synthetize proteins during immobilization [83]. In myocytes, a 
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decrease number of nuclei reduces the transcriptional activity in the surrounding domain of 
cytoplasm of each nucleus (i.e., myonuclear domain), and therefore reduces the overall 
protein synthesis capacity [84]. In myonuclei, DNA fragmentation has been reported in rodent 
during the first days of hindlimb unloading using histological TUNEL staining [85-88]. This 
suggests that apoptosis would be a biological process promoting atrophy through a loss of 
myonuclei during immobilization. Such idea is supported by studies demonstrating that 
caspase-3 activity [59, 89] and the apoptotic mitochondrial intrinsic pathways (i.e., 
endonuclease G and apoptosome) [86, 90] are stimulated in unloaded skeletal muscle. 
However, these results have been challenged [91]. Using an in vivo time-lapse microscopy to 
quantify myonuclei in single muscle fibers, Gundersen and Bruusgaard showed that 14 days 
of hindlimb unloading were not accompanied by a loss of nuclei [91]. Their convincing 
experiment highlighted that, the histological TUNEL staining may lead to confound 
myonuclear and nuclei from stromal/satellite cells [91]. Additional experiments are needed to 
determine whether immobilization does result in a loss of myonuclei.  
Proteolysis plays a major role in immobilization-induced skeletal muscle atrophy. 
Calpains, caspase-3, ubiquitin-proteasome and autophagy-lysosome systems act 
synergistically to stimulate protein breakdown in unloaded skeletal muscle. Although a loss of 
sarcoplasmic proteins occurs, myofibrillar proteins are the main target of proteolysis during 
immobilization [92]. The calpains and caspase-3 are key proteases that initiate muscle 
proteolysis by degrading sarcomeres. Indeed, calpains breakdown structural proteins like titin, 
nebulin or α-fodrin [93], whereas caspase-3 targets intact actomyosin [94]. The breakdown of 
sarcomeric proteins releases actin and myosin, which in turn are degraded by the ubiquitin 
proteasome system (UPS). In skeletal muscle, recent studies demonstrated that both calpains 
and caspase-3 were activated by hindlimb unloading [59, 95, 96]. Interestingly, 
pharmacological inhibition of calpains or caspase-3 prevents type I fibers atrophy observed in 
casted rats, demonstrating that these proteases are mandatory for skeletal muscle atrophy [89]. 
These results also suggest that activation of caspase-3 signaling pathway contributes to 
skeletal muscle atrophy independently from a loss of myonuclei. 
Once calpains/caspase-3 system initiates the sarcomeres disassembly, the myofibrillar 
proteins are ubiquinated and degraded by the 26S proteasome complex. The ubiquitin-
activating enzyme (E1) activates ubiquitin, which is then transferred to the ubiquitin 
conjugating protein (E2). The E2 enzyme interacts with an ubiquitin ligase (E3) which 
catalyzes the transfer of ubiquitin to the target protein, marking it for proteasomal 
degradation. The muscle RING finger 1 (MurF1) and muscle atrophy F-box (MAFbx) are the 
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main ubiquitin ligases responsible for protein degradation in skeletal muscle. It is well 
established that immobilization causes an accumulation of polyubiquitinated proteins in 
rodent and human skeletal muscle [96-98] due to increase in both MuRF-1 and MAFbx 
expression [53, 57, 62, 99]. The nuclear factor-κB (NF-κB) directly regulates the transcription 
of MuRF1, and consequently plays an important role in immobilization-induced protein 
degradation [100, 101]. On the one hand, activation of the NF-κB p65-p50 heterodimer is 
regulated through its release from IκBα, thus leading to its nuclear translocation (canonical 
pathway). On the other hand, BCL-3 binding to the NF-κB p50-p50 homodimer is an 
alternative pathway promoting NF-κB activation [102]. Interestingly, the alternative NF-κB 
signaling is required for immobilization-induced skeletal muscle atrophy [102-104], this may 
be not the case for the canonical NF-κB signaling [102]. The Forkhead box subfamily O 
(FOXO) transcription factors regulate the transcription of MAFbx [105, 106], but their role in 
MuRF-1 expression is still under debate [101, 107, 108]. Interestingly, hindlimb unloading 
stimulates FOXO1A and FOXO3A activities in rodent skeletal muscle [81, 101, 109], 
whereas results from unilateral lower limb suspension experiments are less consistent in 
human [110, 111]. The radical model used in rodent, i.e., hindlimb suspension, could explain 
the discrepancy with human experiment. 
In skeletal muscle atrophy, the autophagy-lysosome system operates in a complementary 
manner with UPS. Autophagy is a process characterized by the formation of a double-
membrane vesicle (autophagosome) engulfing cytoplasmic components. Subsequently, 
autophagosome fuses with lysosomes for digestion [112]. This process is regulated by more 
than 30 autophagy-related (Atg) genes. The autophagosome formation is initiated by the small 
ubiquitin-like molecules [microtubule-associated proteins 1A/1B light chain 3A (LC3), 
GABARAP, GATE16 and Atg12]. The latter are activated by E1 enzyme (Atg7) and 
transferred to E2 enzymes (Atg 3 or Atg10). Then, small ubiquitin-like molecules are 
transferred via Atg12-Atg5-Atg16 complex to membranes, which then grow leading to 
autophagosome formation [112]. Autophagy constitutes a quality control mechanism, 
ensuring cell homeostasis and functions. However, its hyperactivation leads to cellular 
dysfunctions and exacerbates muscle loss in atrophying conditions [113]. In skeletal muscle, 
myofibrillar proteins targeted by ubiquitin can have a double fate: 1) recognized and removed 
by the proteasome 26S or 2) docked to the autophagosome. In the latter case, polyubiquitin 
chains interact with the ubiquitin binding protein p62 which possesses an interaction domain 
with LC3. This mechanism brings then ubiquitinated proteins to the growing autophagosome. 
Interestingly, Cannavino and colleagues reported an elevation of p62 mRNA in the soleus of 
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mice after one week of hindlimb unloading [53, 62]. Moreover, hindlimb unloading and 
casting caused, in skeletal muscle, an increase of LC3 ratio (LC3II/I) [54, 60], a marker of 
autophagy activation. Data in human are scarce and less consistent [114]. All together, the 
results suggest that autophagy plays a role in skeletal muscle loss during immobilization.  
Evidence for a role of RONS in immobilization-induced skeletal muscle atrophy  
In vitro and in vivo evidence strongly support the involvement of RONS in skeletal 
muscle atrophy [115-119]. In the last decade, studies demonstrated that oxidant molecules 
(H2O2 and doxorubicin) stimulate ubiquitin conjugation, upregulated E2 enzyme, MAFbx and 
MuRF-1 gene expression in C2C12 myotubes [118, 120]. Specifically, RONS-dependent p38 
phosphorylation mediates MAFbx expression [115, 119], whereas molecular mechanisms by 
which RONS regulate MuRF-1 expression remain unknown. RONS have been also identified 
as mediators for activation of the calpain system. Using small interfering RNA in C2C12 
myotubes, Talbert and colleagues have demonstrated that, among the different proteases, 
calpain-1 was required for H2O2-induced C2C12 myotubes atrophy [117]. As previously 
described, myonuclear apoptosis is thought to play a role in skeletal muscle atrophy. In 
C2C12 myotubes, H2O2 induces DNA fragmentation mediated by Bax upregulation, 
mitochondrial cytochrome c and apoptosis-inducing factor releases [116], a result supporting 
that RONS overproduction stimulates apoptosis during immobilization.  
In vivo, recent studies support that UPS and autophagy are regulated in a redox-
dependent manner. In skeletal muscle of rats, catalase overexpression prevented 
immobilization-induced skeletal muscle atrophy [121]. Interestingly, this effect was 
associated with a reduction of FOXO and NF-κB activation. These results have been 
confirmed by using antioxidant agents such as EUK-134 (SOD and catalase mimetic) [71] and 
SS-31 (mitochondria-targeted antioxidant) [54, 121]. The inhibition of mitochondrial ROS 
production prevented soleus atrophy and UPS/autophagy activation induced by casting [54], 
whereas EUK-134 limited skeletal muscle atrophy and FOXO3a activation induced by 
hindlimb unloading [71]. Taken together, these data support that RONS activate UPS and 
autophagy in immobilization-induced skeletal muscle atrophy. As previously pointed out, 
xanthine oxidase is an important source of ROS in skeletal muscle during immobilization [57, 
65]. Using allopurinol, an inhibitor of xanthine oxidase, our laboratory demonstrated that this 
strategy partially prevented hindlimb unloading-induced skeletal muscle loss in rats through a 
mechanism involving the p38-MAFbx axis [57]. However, these results contrast with a 
previous study conducted in mice [122], emphasizing the need for further researches. 
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The use of non-pharmacological antioxidants has also been tested to prevent skeletal 
muscle atrophy. Vitamin E and analogs appeared as compounds which prevent muscle 
atrophy induced by immobilization [58, 61, 123]. Specifically, vitamin E would counteract 
muscle atrophy by reducing expression of proteases (caspase-3 and calpains), MuRF-1 and 
MAFbx [61]. Other dietary antioxidant compounds have been recently proposed to prevent 
hindlimb unloading-induced skeletal muscle atrophy. In rats, resveratrol supplementation 
partially prevents skeletal muscle atrophy induced by 14 days of hindlimb unloading [124]. 
The effects of curcumin supplementation on muscle atrophy have been also assessed in both 
mice and rats. Vitadello and colleagues observed, in rats, that daily curcumin injections 
prevented muscle atrophy induced by 10 days of hindlimb unloading [69], whereas others did 
not report any preventive effects in suspended mice fed with a curcumin supplemented diet 
[125]. These contradictory results underscore that dose and mode of administration may 
modulate the effectiveness of antioxidant agents. 
All together, these results highlight that antioxidant supplementation could be a 
promising strategy to prevent skeletal muscle atrophy during immobilization. However, 
additional studies are needed to test whether antioxidant supplementations prevent muscle 
atrophy in bedridden or casted patients. The Figure 2 illustrates the mechanism of RONS-
induced skeletal muscle atrophy in immobilization. 
 
ROLE OF OXIDATIVE STRESS IN PHYSICAL INACTIVITY-INDUCED 
SKELETAL MUSCLE INSULIN RESISTANCE 
Regulation of insulin-dependent glucose uptake in skeletal muscle 
Insulin resistance is defined as an inadequate response to insulin in target tissues. In 
skeletal muscle, insulin resistance results in a reduced ability of insulin to stimulate glucose 
uptake. Given that skeletal muscle accounts for ~80% of insulin-mediated glucose uptake 
[126], alteration of insulin action in myocytes plays a key role in hyperglycemia, the hallmark 
of type 2 diabetes.  
In skeletal muscle, regulation of glucose uptake by insulin is mediated by several 
effectors and culminates with the translocation of glucose transporter 4 (GLUT4) to the 
membrane, thus allowing the entry of glucose into myocytes (Figure 3). Insulin is the master 
regulator of glycemia in post-prandial state. After a meal, increase of glycemia stimulates 
insulin secretion by the pancreatic β-cells. Insulin binds to its transmembrane receptor, the 
insulin receptor (IR). IR is a heterotetramer composed by two extracellular α subunits and two 
transmembrane β subunits linked to each other by disulfide bridges [127]. Insulin interaction 
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with the α subunits activates the tyrosine kinase domain of the β subunits, resulting in 
autophosphorylation of several tyrosine residues located in the juxtamembrane region and 
intracellular C-tail [128]. Tyr960 of IR is a key residue for the regulation of insulin-stimulated 
glucose transport [128]. This docking site recruits proteins which contain a phosphotyrosine 
binding (PTB) domain. Among these proteins, the insulin receptor substrates 1 and 2 (IRS-1 
and IRS-2) mediate most of the insulin effects. IRS-1/2 contains a PTB domain next to a 
pleckstrin homology (PH) domain [129]. Due to its high affinity for phospholipids, the PH 
domain of IRS-1/2 stabilizes the protein at the membrane and facilitates the phosphorylation 
of its PTB domain by IR. Phosphorylated IRS-1/2 on tyrosine residue recruits the regulating 
subunit (p85) of PI3K through its Src homology 2 domain. This interaction leads to the 
activation of PI3K catalytic subunit (p110), which catalyzes the formation of the membrane 
phospholipid phosphatidylinositol 3,4,5-trisphosphate (PIP3) from phosphatidylinositol 4,5-
diphosphate (PIP2) [127]. PIP3 recruits Akt and phosphoinositide-dependent kinase-1 (PDK1) 
to the membrane through their PH domains. The serine/threonine kinase Akt contains a PH 
domain in its N-terminal end, a kinase domain and a C-terminal hydrophobic domain. In 
mammalian, three isoforms of Akt have been identified: Akt1, Akt2 and Akt3. Akt1 is widely 
expressed, whereas Akt3 is principally found in brain and testes. Akt2 expression is 
predominant in adipocytes and myocytes, where it is responsible for glucose uptake [130]. In 
the cytosol, Akt is maintained in an inactive state through an association between its kinase 
and PH domains. When recruited to the membrane by PIP3, Akt is phosphorylated by PDK1 
and mammalian target of rapamycin complex 2 on Thr308 (kinase domain) and Ser473 (C-
terminal domain), respectively. Akt activity increases by 100-fold when phosphorylated on 
Thr308, but full activation requires Ser473 phosphorylation [130]. Activated Akt returns to the 
cytosol and phosphorylates the TBC1 family member 1 (TBC1D1) and 4 (TBC1D4, formerly 
known as Akt substrate 160, AS160). TBC1D1/TBC1D4 proteins exhibit GTPase activity 
toward several G proteins, namely Rab, which are associated with GLUT4 storage vesicles 
(GSVs). This GTPase activity is inhibited by Akt phosphorylation, leading to an increase of 
the active forms of Rab, i.e., Rab GTP-bound form [131]. Activated Rab promotes all the 
steps of GLUT4 exocytosis: approach, tethering, docking and fusion [132].  
Upon insulin stimulation, the cytoskeleton provides tracks for the displacement of GSVs 
and insulin effectors such as IRS-1/2, PI3K and Akt. Recently, cytoskeletal reorganization 
appeared as an essential step of insulin-mediated glucose uptake, a process involving the G 
protein Rac1 in myocytes [133].  
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Physical inactivity causes skeletal muscle insulin resistance 
Insulin resistance is generally diagnosed in fasting state via the homeostasis model 
assessment-estimated insulin resistance (HOMA-IR) [134], or with the Matsuda index in the 
dynamic state [135]. Using these clinical tools, numerous epidemiological and experimental 
studies have clearly demonstrated, in human, that physical inactivity promotes insulin 
resistance [136-140]. Based on the physical inactivity threshold determined by the WHO, the 
epidemiological RISC and ATTICA studies highlighted that physically inactive people 
exhibited higher HOMA-IR values, and this was independent from the body mass index [136, 
137]. Human experimental studies confirmed these data by demonstrating that a reduction of 
daily steps from more than 10,000 to less than 1,500 steps/day increased the HOMA-IR and 
Matsuda index after only 5 days [139, 140]. Specifically, reduction in daily steps during 14 
days has been associated with peripheral insulin resistance and inhibition of insulin-stimulated 
Akt phosphorylation in skeletal muscle [141]. In rodents, similar results have been reported 
by using the locked-wheel model. Indeed, a reduction in insulin-stimulated glucose uptake 
was observed in skeletal muscle 53h after cessation of physical activity [142]. Interestingly, 
alteration in muscle glucose uptake was associated with a reduction of GLUT4 protein 
content, IR-tyrosine and Akt phosphorylations [142]. Unfortunately, studies exploring the 
cellular mechanisms responsible for physical inactivity-induced muscle insulin resistance are 
scarce [143].  
 
Evidence for a role of RONS in skeletal muscle insulin resistance  
At a cellular level, insulin resistance is a transduction defect of the insulin signaling. The 
physiopathology of insulin resistance remains difficult to apprehend since it results from a 
complex integration of diverse cellular disorders: inflammation [144], intra/extracellular 
lipids accumulation [145, 146], mitochondrial dysfunction [147] and oxidative stress [8]. 
However, a large body of evidence highlights that disruption of redox homeostasis could be a 
common factor by which these cellular disorders inhibit insulin signaling [148, 149]. In L6 
myotubes, SOD mimetic or SOD overexpression reduced insulin resistance induced by the 
tumor necrosis factor α (TNFα), chronic insulin or dexamethasone [150]. In addition, 
palmitate-induced insulin resistance in L6 myotubes was prevented by two chemical agents 
which reduce mitochondrial superoxide production [150]. In leptin-deficient ob/ob mice, SOD 
mimetic improved whole-body insulin sensitivity [151]. As described herein, considerable 
evidence shows that oxidative stress is a central player in the development of insulin 
resistance. In the literature, several mechanisms have been proposed, they include: 1) IRS-1/2 
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serine phosphorylation; 2) reduction of GLUT4 protein expression; 3) alteration of the 
molecular traffic required for insulin action; 4) insulin effectors oxidation. 
The mechanism by which oxidative stress induces insulin resistance is mainly based on 
IRS-1/2 serine phosphorylation caused by the redox-sensitive kinases p38, c-Jun amino-
terminal kinase (JNK), IκB kinase β (IKKβ) and extracellular signal-regulated kinases 
(ERK1/2) [152]. IRS-1/2 serine phosphorylation enhances its degradation and reduces its 
tyrosine phosphorylation, inhibiting de facto the insulin signaling [8]. In addition, oxidative 
stress activates NF-κB which in turn upregulates TNFα, an inflammatory cytokine inhibiting 
insulin signaling through IKKβ activation [153]. However, caution must be taken when 
generalizing these mechanisms to skeletal muscle. Muscle-specific JNK or IKKβ deficient 
mice were not protected against obesity-induced insulin resistance [154, 155]. In addition, 
overactivation of NF-κB and IKKβ in skeletal muscle does not lead to insulin resistance 
[156]. Finally, the role of IRS-1/2 serine phosphorylation in the development of insulin 
resistance has been challenged [157, 158]. In skeletal muscle, more studies are needed to 
determine the implication of p38, JNK, IKKβ, ERK and NF-κB in oxidative stress-induced 
insulin resistance. 
The downregulation of GLUT4 protein expression is a proposed mechanism by which 
oxidative stress disrupts insulin sensitivity [44]. Although that seems relevant in adipose 
tissue [8, 159, 160], this is not the case in skeletal muscle. Indeed, GLUT4 protein expression 
is, in most of the cases, unaltered in skeletal muscle of type 2 diabetic patients despite 
evidence for oxidative stress [161, 162]. In addition, exercise (single bout or training) is well 
known to stimulate both GLUT4 expression and RONS production in skeletal muscle [163]. 
Consequently, oxidative stress seems unlikely associated with GLUT4 downregulation in 
skeletal muscle. 
As described above, activation of some insulin effectors requires their displacement from 
one subcellular compartment to another. Some studies reported that such protein movements 
are redox-sensitive. In skeletal muscle of rats, insulin-stimulated subcellular redistribution of 
tyrosine-phosphorylated IRS-1 and p85 were altered by oxidative stress induced by an 
inhibitor of glutathione synthesis [164]. Similar results were obtained in adipose tissue and 
3T3-L1 adipocytes [164, 165]. Additional evidences revealed that, in L6 myotubes, oxidative 
stress prevents insulin-induced actin reorganization [166]. Consequently, the molecular traffic 
required for insulin action could be regulated in a redox-dependent manner. 
In the context of insulin resistance, studies showed that several insulin effectors are 
nitrosylated, a mechanism thought to inhibit insulin signaling. Indeed, insulin-stimulated Akt 
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phosphorylation and activity were reduced in the skeletal muscle of diabetic db/db mice, this 
was associated with a drastic increase of Akt S-nitrosylation [167]. In the skeletal muscle of 
high-fat-fed rats and ob/ob mice, Carvalho-Filho et al. found a reduction of insulin-stimulated 
IR, IRS-1 and Akt phosphorylations, which was associated with an increase of their S-
nitrosylations [168]. In ob/ob mice, these effects were prevented by the downregulation of 
iNOS [168], suggesting a role of this enzyme in oxidative stress-induced insulin resistance. 
Additional evidence indicated that IRS-1 S-nitrosylation promotes its degradation in skeletal 
muscle [168]. Moreover, S-nitrosylation of Akt reduced its activity in C2C12 myotubes [167]. 
Consequently, S-nitrosylation of insulin effectors appears as a mechanism able to regulate 
insulin signaling in muscle fibers. In adipocytes, other studies pointed out a potential role of 
lipid peroxidation, protein nitration and carbonylation in the development of insulin resistance 
[169-171]. The Figure 4 illustrates the proposed mechanisms of RONS-induced insulin 
resistance in skeletal muscle.  
As described in this section, physical inactivity and oxidative stress contribute to insulin 
resistance. However, it is currently unknown whether oxidative stress mediates physical 
inactivity- induced insulin resistance.  
 
Oxidant molecules: Doctor Jekyll and Mister Hyde 
Although attractive, the hypothesis developed in this section has been challenged. Indeed, 
antioxidant supplementation such as vitamin C and E provided disappointing results in type 2 
diabetic patients [172]. As a consequence, this therapeutic strategy is not recommended to 
improve insulin action [172]. These puzzling results could be related to the complex relation 
between oxidative stress and insulin signaling. Depending on dose and exposure time, oxidant 
molecules are able to either inhibit or promote insulin action. As described above, RONS 
disrupt insulin signaling. However, RONS are also second messengers facilitating the 
transduction of insulin signaling [8]. These two faces of oxidant molecules may partly explain 
the failure of therapies seeking to alleviate oxidative stress in type 2 diabetes. Moreover, in 
human, antioxidant supplementation prevented the beneficial effect of exercise on insulin 
sensitivity [173], thus suggesting that therapies combining exercise and antioxidant are 
counterproductive. Taken together, these results indicate that the current antioxidants are not 
useful to fight against insulin resistance. However, other antioxidant strategies may prevent 
insulin resistance. Indeed, redox homeostasis appears as a complex system involving multiple 
RONS and antioxidant defenses operating in different compartments within tissues and cells. 
Moreover, RONS regulate essential processes to cell functions. Thus, several questions 
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deserve to be asked when using antioxidant: Which RONS is targeted ? Which source is 
targeted ? In what proportion RONS concentration should be reduced ?  
 
CONCLUDING REMARKS 
In this review, we examined the role of oxidative stress on physical inactivity and 
immobilization-induced, respectively, skeletal muscle insulin resistance and atrophy. First, in 
the literature a major confusion exists between the terms physical inactivity and 
immobilization. Physical inactivity is frequently associated with experiments where subjects 
are immobilized. Thus, caution must be taken when interpreting results from these studies. 
For the sake of clarity, we chose to make a clear distinction between physical inactivity and 
immobilization. We pointed out that skeletal muscle atrophy due to immobilization is a 
RONS-dependent process. In this condition, antioxidants provided promising results in 
animals, they need to be tested in human. On the other hand, the involvement of oxidative 
stress in physical inactivity-induced insulin resistance has not been investigated. This lack of 
data is, we believe, related to the confusion between physical inactivity and immobilization. 
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Figure 1. Human and rodent models used to study immobilization and physical 
inactivity. WHO: World Health Organization. 
Figure 2. Mechanism of RONS-induced skeletal muscle atrophy in immobilization UPS: 
ubiquitin proteasome system; RONS: reactive oxygen and nitrogen species. 
Figure 3. Regulation of glucose uptake by insulin. See details in the text. IR: insulin 
receptor; IRS: insulin receptor substrate; GLUT4: glucose transporter 4; mTORC2: 
mammalian target of rapamycin complex 2; PDK1: phosphoinositide-dependent kinase-1; 
PIP2: phosphatidylinositol 4,5-diphosphate; PIP3: phosphatidylinositol 3,4,5-trisphosphate; 
PI3K: phosphatidyl inositol 3-kinase. 
Figure 4. Proposed mechanisms of RONS-induced insulin resistance in skeletal muscle. 
The effect of physical inactivity on skeletal muscle oxidative stress is currently unknown. 
RONS: reactive oxygen and nitrogen species.  
 
 
HIGHLIGHTS 
 The terms physical inactivity and immobilization are a source of confusion in the 
literature 
 Immobilization alters redox homeostasis in skeletal muscle 
 RONS play a key role in immobilization-induced skeletal muscle atrophy 
 Lack of data regarding the effect of physical inactivity on skeletal muscle 
oxidative stress 
 The role of RONS in physical inactivity-induced insulin resistance needs to be 
investigated 
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